Company intelligence / Profile preview

Ori Biotech

London, United Kingdomoribiotech.com ↗
Ownership
Private
Development stage
Commercial
01

Overview

Ori Biotech has developed a proprietary automated cell and gene therapy manufacturing platform aimed at making advanced therapies more scalable, affordable, and accessible. The IRO® system automates and standardizes the production process from preclinical through commercial scale. As a technology/platform provider rather than a therapeutic developer, Ori does not have its own clinical results or pipeline but supports partners across the cell/gene therapy field. The company raised over $100 million in Series B funding in January 2022 to support transition from pre-commercialization toward market launch.

Therapeutic areas
Other
Modalities
Cell therapyGene therapyDevice (manufacturing platform)Biologic (enabling technology for biologics manufacturing)
Industry
Non-Drug Biotech
02

Partnerships

Collaborations with leading academic institutions, biotechnology/pharmaceutical/technology companies developing new approaches for personalized treatments. Specific names are not disclosed.

Beyond the preview

Go deeper on Ori Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ori Biotech.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call